메뉴 건너뛰기




Volumn 26, Issue 9, 2011, Pages 3046-3050

CYP3A5 and ABCB1 polymorphisms in donor and recipient: Impact on Tacrolimus dose requirements and clinical outcome after renal transplantation

Author keywords

pharmacogenetics; tacrolimus; transplantation

Indexed keywords

CYTOCHROME P450 3A5; MULTIDRUG RESISTANCE PROTEIN 1; TACROLIMUS;

EID: 80053184901     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfr253     Document Type: Article
Times cited : (74)

References (13)
  • 1
    • 42649096927 scopus 로고    scopus 로고
    • Trends in kidney transplantation over the past decade
    • DOI 10.2165/00003495-200868001-00002
    • Knoll G. Trends in kidney transplantation over the past decade. Drugs 2008; 68: 3-10 (Pubitemid 351601432)
    • (2008) Drugs , vol.68 , Issue.SUPPL. 1 , pp. 3-10
    • Knoll, G.1
  • 2
    • 42149136030 scopus 로고    scopus 로고
    • Biotransformation enzymes and drug transporters pharmacogenetics in relation to immunosuppressive drugs: Impact on pharmacokinetics and clinical outcome
    • Mourad M, Wallemacq P, De Meyer et al. Biotransformation enzymes and drug transporters pharmacogenetics in relation to immunosuppressive drugs: impact on pharmacokinetics and clinical outcome. Transplantation 2008; 85: 19-24
    • (2008) Transplantation , vol.85 , pp. 19-24
    • Mourad, M.1    Meyer De, W.P.2
  • 3
    • 60849086797 scopus 로고    scopus 로고
    • Individualization of immunosuppression: Concepts and rationale
    • WavamunnoMD, Chapman JR. Individualization of immunosuppression: concepts and rationale. Curr Opin Organ Transplant 2008; 13: 604-608
    • (2008) Curr Opin Organ Transplant , vol.13 , pp. 604-608
    • Wavamunno, M.D.1    Chapman, J.R.2
  • 4
    • 34548083672 scopus 로고    scopus 로고
    • Cytochrome P450 3A polymorphisms and immunosuppressive drugs: An update
    • DOI 10.2217/14622416.8.7.835
    • Anglicheau D, Legendre C, Beaune P et al. Cytochrome P450 3A polymorphisms and immunosuppressive drugs: an update. Pharmacogenomics 2007; 8: 835-849 (Pubitemid 47288980)
    • (2007) Pharmacogenomics , vol.8 , Issue.7 , pp. 835-849
    • Anglicheau, D.1    Legendre, C.L.2    Beaune, P.3    Thervet, E.4
  • 5
    • 33645864935 scopus 로고    scopus 로고
    • Effect of CYP3A5 polymorphism on tacrolimus metabolic clearance in vitro
    • Dai Y, Hebert MF, Isoherranen N et al. Effect of CYP3A5 polymorphism on tacrolimus metabolic clearance in vitro. Drug Metab Dispos 2006; 34: 836-847
    • (2006) Drug Metab Dispos , vol.34 , pp. 836-847
    • Dai, Y.1    Hebert, M.F.2    Isoherranen, N.3
  • 7
    • 1542373607 scopus 로고    scopus 로고
    • Association between ABCB1 (multidrug resistance transporter) genotype and post-liver transplantation renal dysfunction in patients receiving calcineurin inhibitors
    • DOI 10.1097/00008571-200311000-00002
    • Hebert MF, Dowling AL, Gierwatowski C et al. Association between ABCB1 (multidrug resistance transporter) genotype and post-liver transplantation renal dysfunction in patients receiving calcineurin inhibitors. Pharmacogenetics 2003; 13: 661-674 (Pubitemid 38316510)
    • (2003) Pharmacogenetics , vol.13 , Issue.11 , pp. 661-674
    • Hebert, M.F.1    Dowling, A.L.S.2    Gierwatowski, C.3    Lin, Y.S.4    Edwards, K.L.5    Davis, C.L.6    Marsh, C.L.7    Schuetz, E.G.8    Thummel, K.E.9
  • 8
    • 72049101913 scopus 로고    scopus 로고
    • Donor age and renal P-glycoprotein expression associate with chronic histological damage in renal allografts
    • Naesens M, Lerut E, de Jonge H et al. Donor age and renal P-glycoprotein expression associate with chronic histological damage in renal allografts. J Am Soc Nephrol 2009; 20: 2468-2480
    • (2009) J Am Soc Nephrol , vol.20 , pp. 2468-2480
    • Naesens, M.1    Lerut, E.2    De Jonge, H.3
  • 9
    • 25144433260 scopus 로고    scopus 로고
    • Multidrug resistance polypeptide 1 (MDR1, ABCB1) variant 3435C>T affects mRNA stability
    • Wang D, Johnson AD, Papp AC et al. Multidrug resistance polypeptide 1 (MDR1, ABCB1) variant 3435C〉T affects mRNA stability. Pharmacogenet Genomics 2005; 15: 693-704 (Pubitemid 41345321)
    • (2005) Pharmacogenetics and Genomics , vol.15 , Issue.10 , pp. 693-704
    • Wang, D.1    Johnson, A.D.2    Papp, A.C.3    Kroetz, D.L.4    Sadee, W.5
  • 11
    • 33748710224 scopus 로고    scopus 로고
    • Multidrug resistance gene-1 (MDR-1) haplotypes have a minor influence on tacrolimus dose requirements
    • DOI 10.1097/01.tp.0000234942.78716.c0, PII 0000789020060915000017
    • Fredericks S, Moreton M, Reboux S et al. Multidrug resistance gene-1 (MDR-1) haplotypes have a minor influence on tacrolimus dose requirements. Transplantation 2006; 82: 705-708 (Pubitemid 44395243)
    • (2006) Transplantation , vol.82 , Issue.5 , pp. 705-708
    • Fredericks, S.1    Moreton, M.2    Reboux, S.3    Carter, N.D.4    Goldberg, L.5    Holt, D.W.6    MacPhee, I.A.M.7
  • 13
    • 77952585319 scopus 로고    scopus 로고
    • Optimization of initial tacrolimus dose using pharmacogenetic testing
    • Thervet E, Loriot MA, Barbier S et al. Optimization of initial tacrolimus dose using pharmacogenetic testing. Clin Pharmacol Ther 2010; 87: 721-726
    • (2010) Clin Pharmacol Ther , vol.87 , pp. 721-726
    • Thervet, E.1    Loriot, M.A.2    Barbier, S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.